ONL THERAPEUTICS
Live / Registered — Registered (as of 05 Jul 2022)
What this means for you
Registered since 05 Jul 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88698300
- Registration number
- 6782797
- Mark type
- Stylized text
- Filed
- 19 Nov 2019
- Published for opposition
- 20 Oct 2020
- Registered
- 05 Jul 2022
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of retinal disease
Owner
- ONL Therapeutics, Inc., Ann Arbor, MI, US
- ONL Therapeutics, Inc., Ann Arbor, MI, US
- ONL Therapeutics, Inc., Ann Arbor, MI, US
Prosecution history
- 05 Jul 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 05 Jul 2022 — REGISTERED-PRINCIPAL REGISTER
- 03 Jun 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Jun 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 24 May 2022 — ASSIGNED TO EXAMINER
- 08 Apr 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 09 Mar 2022 — USE AMENDMENT FILED
- 06 Apr 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 09 Mar 2022 — TEAS STATEMENT OF USE RECEIVED
- 18 Nov 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Nov 2021 — SOU EXTENSION 2 GRANTED
- 16 Nov 2021 — SOU EXTENSION 2 FILED
- 16 Nov 2021 — SOU TEAS EXTENSION RECEIVED
- 09 Jun 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jun 2021 — SOU EXTENSION 1 GRANTED